Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring
暂无分享,去创建一个
A. Teigler‐Schlegel | D. Reinhardt | U. Creutzig | F. Griesinger | C. Langebrake | U. Puhlmann | Iris Brinkmann
暂无分享,去创建一个
A. Teigler‐Schlegel | D. Reinhardt | U. Creutzig | F. Griesinger | C. Langebrake | U. Puhlmann | Iris Brinkmann